StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was $6.54, up 45.3% from the year before. Over ten years it grew 11.4% a year on average. The highest annual figure on record is $6.54 in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Dec 31, 2025$6.54+45.3%
FY2024Dec 31, 2024$4.50+18.1%
FY2023Dec 31, 2023$3.81+80.6%
FY2022Dec 31, 2022$2.11+2537.5%
FY2021Dec 31, 2021$0.08-96.7%
FY2020Dec 31, 2020$2.44+136.9%
FY2019Dec 31, 2019$1.03-39.4%
FY2018Dec 31, 2018$1.70-28.3%
FY2017Dec 31, 2017$2.37-14.1%
FY2016Dec 31, 2016$2.76+23.8%
FY2015Dec 31, 2015$2.23–

Quarterly eps

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.61+600.0%
Q2 FY2025Jun 30, 2025$1.57+273.8%
Q2 FY2024Jun 30, 2024$1.24+113.8%
Q2 FY2023Jun 30, 2023$1.17+1070.0%
Q2 FY2022Jun 30, 2022$0.23-14.8%
Q2 FY2021Jun 30, 2021$0.42+10.5%
Q2 FY2020Jun 30, 2020$0.58–
Q2 FY2019Jun 30, 2019$0.10–
Q2 FY2018Jun 30, 2018$0.27–
Q2 FY2017Jun 30, 2017$0.38–

More AstraZeneca figures

See a number that looks wrong?